ADMA Biologics, Inc.

ADMANASDAQHealthcare● Active

$8.10

+$0.13(+1.57%)

Market Cap$1.9B

P/E Ratio—

52W High$22.37

52W Low$7.21

Avg Volume7.0M

Open$7.89

Beta0.73

Net Income Financials Revenue

ADMA Biologics, Inc. (ADMA) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

ADMA · net income · updated Jun 8, 2026

Core profitability metrics

ADMA · net income · margin · TTM · CAGR

Net income was $146.9M for FY2025 (fiscal year ending 2025-12-31), down 25.7% year-over-year. Net profit margin was 28.8%. Based on available data, ADMA Biologics, Inc. has been profitable since at least 2024.

FY2025 Net Income$146.9M▼ -25.7% YoY

Trailing 12M (TTM)$165.4Mtrailing 4 quarters sum

Net Profit Margin28.8%$146.9M ÷ $510.2M

YoY Change-25.7%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 8, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %★ First Profit: 2024

▸ FMP /income-statement · Annual · ADMA net income history · ADMA profit margin

Annual net income data

ADMA · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025$146.9M▼ 25.7%28.8%$510.2M

FY2024★ First Profit$197.7M▲ +800.0%46.4%$426.5M

FY2023Loss−$28.2M▲ +57.2%-10.9%$258.2M

FY2022Loss−$65.9M▲ +8.0%-42.8%$154.1M

FY2021Loss−$71.6M▲ +5.4%-88.5%$80.9M

Net income vs peers (Healthcare)

ADMA vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

ADMA Biologics, Inc.YOU

ADMA

$146.9M-25.7%28.8%

Eli Lilly and Company

LLY

$20.64B+94.9%31.7%

77%

UnitedHealth Group Incorporated

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

ADMA Biologics, Inc. (ADMA) reported net income of $146.9M for FY2025 (fiscal year ending 2025-12-31), down 25.7% year-over-year. The net profit margin was 28.8% — meaning the company kept $0.29 of every dollar of revenue as profit.

Based on available data, ADMA Biologics, Inc. has been profitable since at least 2024. Net income reached a peak of $197.7M in FY2024. Data available for 15 fiscal years.

ADMA Biologics, Inc.'s net profit margin was 28.8% for FY2025, based on the latest annual results.

Investors sometimes search for "ADMA Biologics, Inc. net worth" — the company's market capitalization is a separate figure from ADMA net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

ADMA net income · 5 questions

ADMA Biologics, Inc. is profitable. The company reported net income of $146.9M for FY2025, a net profit margin of 28.8%. Net income was down 25.7% year-over-year. Based on available data, ADMA Biologics, Inc. has been profitable since at least 2024.

is ADMA profitabledoes ADMA make a profitADMA profitabilityADMA profitable company

▸ Source: FMP /income-statement · GAAP · ADMA Biologics, Inc. · ADMA Biologics, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026